肺癌筛查的资格标准越来越需要考虑肺癌家族史以及年龄和吸烟状况。肺癌筛查将揭示大量偶然发现，具有不同的临床意义，并且需要明确的治疗途径。程序内成像和尖端机器人技术增强了肺结节采样。系统性胸部淋巴结取样对治疗效果具有影响。支气管镜消融技术对于周围型肺癌是可行的。支气管镜取样在肺癌分子表征方面仍然具有很高的产率。免疫治疗适应症已扩大到包括早期和可切除肺癌。© 2024 作者。约翰·威利出版的《呼吸学》

Eligibility criteria for lung cancer screening increasingly need to consider family history of lung cancer, as well as age and smoking status. Lung cancer screening will reveal a multitude of incidental findings, of variable clinical significance, and with a need for clear pathways of management. Pulmonary nodule sampling is enhanced by intra-procedural imaging and cutting-edge robotic technology. Systematic thoracic lymph node sampling has implications for treatment efficacy. Bronchoscopic ablative techniques are feasible for peripheral lung cancers. Bronchoscopic sampling continues to have a high yield for lung cancer molecular characterization. Immunotherapy indications have expanded to include early stage and resectable lung cancer.© 2024 The Author(s). Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.